RL
Robert LeBoyer Noble Capital Markets Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Tonix Pharmaceuticals
TNXP
$222M
| $25.82 | $70 |
171%
upside
| Outperform |
20 Mar ‘25
5 months ago |
|
2
Nutriband
NTRB
$74.7M
| $6.08 | $13 |
114%
upside
| Outperform |
22 Jan ‘25
7 months ago |
|
3
GeoVax Labs
GOVX
$17.7M
| $0.6890 | $10 |
1,351%
upside
| Outperform |
19 Aug ‘24
1 year ago |
|
4
Unicycive Therapeutics
UNCY
$77.2M
| $4.38 | $60 |
1,270%
upside
| Outperform |
14 Feb ‘24
1 year ago |
|
5
Cadrenal Therapeutics
CVKD
$27.4M
| $13.09 | $60 |
358%
upside
| Outperform |
18 Dec ‘23
1 year ago |
|
6
Eledon Pharmaceuticals
ELDN
$154M
| $2.68 | $10 |
273%
upside
| Outperform |
27 Sep ‘23
1 year ago |
|
7
MAIA Biotechnology
MAIA
$52.5M
| $1.59 | $14 |
781%
upside
| Outperform |
21 Feb ‘23
2 years ago |
|
8
Lineage Cell Therapeutics
LCTX
$283M
| $1.27 | $8 |
530%
upside
| Outperform |
19 Aug ‘21
4 years ago |
|
9
Plus Therapeutics
PSTV
$47.4M
| $0.4933 | $120 |
24,226%
upside
| Buy |
25 Jan ‘21
4 years ago |
|
10
Anavex Life Sciences
AVXL
$803M
| $10.26 | $12 |
17%
upside
| Buy |
28 Sep ‘20
5 years ago |
|
11
CNS Pharmaceuticals
CNSP
$3.67M
| $6.60 | $9,900,000 |
149,999,900%
upside
| Buy |
24 Aug ‘20
5 years ago |
|